{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Perioperative Aspirin in Vascular Surgery: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "POISE-2 was a blinded, randomised controlled trial"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "patients assigned to aspirin or placebo"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was a composite of death or myocardial infarction at 30 days."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Patients, clinicians, and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "The study included 603 vascular surgery patients, with 319 in the continuation and 284 in the initiation stratum."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "the primary outcome occurred in 13.7% with aspirin and 9.0% with placebo (HR 1.48, 95% CI 0.71 to 3.09)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Bleeding rates were similar between groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT01082874."
      },
      "Funding": {
        "score": 0,
        "evidence": "The study was funded by [source of funding not provided in the abstract]."
      }
    },
    "total_score": 17,
    "max_score": 25
  },
  "model": "gpt-4o"
}